查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球柳葉刀市場：按類型（安全柳葉刀、標準柳葉刀）、應用、規格尺寸、年齡組、最終用戶和地區劃分的未來預測（至 2028 年）
市場調查報告書
商品編碼
1284875

全球柳葉刀市場：按類型（安全柳葉刀、標準柳葉刀）、應用、規格尺寸、年齡組、最終用戶和地區劃分的未來預測（至 2028 年）

Lancets Market by Type (Safety Lancets, Standard Lancets, Application, Gauze Size, Age Group, End Users, Region - Global Forecast to 2028
出版日期: | 出版商: MarketsandMarkets | 英文 212 Pages | 訂單完成後即時交付

價格
簡介目錄

全球柳葉刀市場規模預計將從 2023 年的 23 億美元增長到 2028 年的 36 億美元，在預測期內以 9.7% 的複合年增長率增長。 柳葉刀市場的增長主要受糖尿病患病率增加、慢性病患病率高以及老年人口增加的推動。 然而，與柳葉刀相關的針刺傷風險、柳葉刀的重複使用以及由於報銷減少和預算限制導致的價格壓力限制了該市場的增長。

“按類型劃分，安全採血針細分市場將在預測期內佔據最高的市場份額”

安全採血針分為手動驅動和自動/壓力驅動。 隨著人口老齡化的加劇，按鈕式刺血針和側按鈕式刺血針將出現最高的增長。

“根據應用，葡萄糖測試將在預測期內實現最高的複合年增長率”

從應用來看，血糖檢測預計將在 2022 年佔據市場主導地位，並實現最高增長率。 支持市場增長的因素是糖尿病患病率的上升和自我監測設備的日益採用。

“按地區劃分，北美在預測期內將佔據最高的市場份額”

按地區劃分，預計北美在預測期內將佔據較高的市場份額。 醫院和外科中心的增加以及各種慢性病患病率的上升也推動了柳葉刀市場的增長。

內容

第一章簡介

第 2 章研究方法

第 3 章執行摘要

第 4 章重要注意事項

第 5 章市場概述

  • 簡介
  • 市場動態
    • 驅動程序
    • 制約因素
    • 機會
    • 任務
  • 價值鏈分析
  • 供應鏈分析
  • 波特五力分析
  • 主要利益相關者和採購標準
  • 監管狀況
  • 貿易分析
  • 生態系統分析
  • 專利分析
  • 主要會議和活動 (2023-2024)
  • 價格分析
  • 影響客戶業務的趨勢/干擾
  • 技術分析

第 6 章柳葉刀市場：按類型

  • 簡介
  • 安全採血針
    • 手動驅動柳葉刀
    • 自驅動/壓力驅動柳葉刀
  • 標準柳葉刀

第 7 章《柳葉刀》市場：按規格尺寸

  • 簡介
  • 22G 或更少
  • 23G 到 33G
  • 超過33G

第 8 章《柳葉刀》市場：按年齡組

  • 簡介
  • 成人
  • 兒科

第 9 章《柳葉刀》市場：按應用劃分

  • 簡介
  • 葡萄糖測試
  • 血紅蛋白測試
  • 凝血試驗
  • 膽固醇測試
  • 過敏測試
  • 新生兒篩查
  • 其他用途

第 10 章《柳葉刀》市場：按最終用戶劃分

  • 簡介
  • 醫院、診所、門診手術中心
  • 家庭護理
  • 其他最終用戶

第 11 章按地區劃分的柳葉刀市場

  • 簡介
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 意大利
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 韓國
    • 亞太地區其他地區
  • 其他地區
    • 拉丁美洲
    • 中東和非洲

第十二章競爭格局

  • 概覽
  • 頂級公司的收入份額分析
  • 市場份額分析
  • 競爭領導力映射
  • 中小企業/初創企業企業評估象限
  • 競爭基準測試
  • 企業足跡分析
  • 競爭場景

第13章公司簡介

  • 主要公司
    • BECTON, DICKINSON AND COMPANY
    • F. HOFFMANN-LA ROCHE LTD.
    • YPSOMED
    • B. BRAUN SE
    • TERUMO CORPORATION
    • GREINER BIO-ONE INTERNATIONAL GMBH
    • ABBOTT LABORATORIES
    • OWEN MUMFORD
    • HTL-STREFA S.A.
    • ARKRAY, INC.
    • SARSTEDT AG & CO. KG
    • STERILANCE MEDICAL (SUZHOU) INC.
    • MEDLINE INDUSTRIES
    • AGAMATRIX, INC.
    • ACON LABORATORIES, INC.
    • SANLI MEDICAL & HEALTH SERVICE
    • ALLISON MEDICAL, INC.
    • GLUCORX LIMITED
  • 其他公司
    • FL MEDICAL S.R.L
    • MHC MEDICAL PRODUCTS, LLC
    • NEOMEDIC
    • CML BIOTECH LTD.
    • DISERA TIBBI MALZEME LOJISTIK SANAYI VE TICARET A.S.
    • A. MENARINI DIAGNOSTICS S.R.L

第14章附錄

簡介目錄
Product Code: MD 7166

The lancets market is projected to reach USD 3.6 Billion by 2028 from USD 2.3 Billion in 2023, at a CAGR of 9.7% during the forecast period. Growth in the lancets market is mainly driven by the growing prevalence of diabetes, the high prevalence of chronic diseases and the rising geriatric population. However, the risk of lancet-related needlestick injuries, the reuse of lancets, and Pricing pressure owing to reimbursement cuts and budget constraints are restricting the growth of this market.

"The Safety lancet segment accounted for the highest market share in the lancets systems market, by type, during the forecast period"

Based on the type of segment, the lancets system market is categorized into standard lancets and safety lancets. Safety lancet are sub categorized into Manually Activated and Automatically activated/Pressure activated. Push Button Lancets and Side Button Lancets Manually Activated are expected to the highest growth in the market which attributed to the growing geriatric population.

"Glucose Testing application accounted for the highest CAGR during the forecast period."

Based on type, the application market is segmented into Glucose Testing, Hemoglobin Testing, Coagulation Testing, Cholesterol Testingm, Allergy Testing, Neonatal Screening and Other Applications. In 2022, the Glucose Testing dominated the market and the lancets market to observe the highest growth rate. Factors supporting the growth of the market is due to the growing prevalence of diabetes and increasing adoption of self-monitoring devices.

"The North America segment accounted for the highest market share in the lancets systems market, by region, during the forecast period"

Based on the region, the global lancets market is categorized into North America, Europe, Asia Pacific, and Rest of the world. North America is expected to witness high market share during the forecast period. Rising prevalence of various chronic diseases which is attributed to the demand of rising number of hospitals and surgical centers are also supporting the growth of the lancets market.

Breakdown of supply-side primary interviews, by company type, designation, and region:

  • By Company Type: Tier 1 (32%), Tier 2 (46%), and Tier 3 (22%)
  • By Designation: C-level (40%), Director-level (26%), and Others (32%)
  • By Region: North America (35%), Asia- Pacific (21%), Europe (30%), Latin America (14%) and Middle East & Africa(3%)

Prominent companies include Becton, Dickinson and Company (US), F. Hoffmann-La Roche Ltd. (Switzerland), B. Braun SE (Germany), Abbott Laboratories (US), Greiner Bio-One International GmbH (Austria), Ypsomed (Switzerland), Terumo Corporation (Japan), Owen Mumford (UK), HTL-STREFA S.A. (Poland), ARKRAY, Inc. (Japan), SARSTEDT AG & Co. KG (Germany), SteriLance Medical (China), Medline Industries (US), AgaMatrix Holdings LLC (US), ACON Laboratories, Inc. (US), SANLI Medical & Health Service (China), Allison Medical Inc. (US), GlucoRx Limited (UK), FL Medical s.r.l. (Italy), A. Menarini Diagnostics s.r.l (Italy), CML Biotech (India), Neomedic (Spain), MHC Medical Products (US), and Disera TIbbi Malzeme Lojistik Sanayi ve Ticaret A.S. (Turkey).

Research Coverage

This research report categorizes the lancets market by type (Safety and Standard lancets), by application (Glucose Testing, Hemoglobin Testing, Coagulation Testing, Cholesterol Testing, Allergy Testing, Neonatal Screening and Other Applications), by end user (Hospitals, Clinics and Ambulatory Surgery Centers, Homecare settings and Other end users (Diagnostic centers, Nursing Homes, Long Term Acute Care Centers, Emergency Medical Service Providers, and Academic Research Institutes), and region (North America, Europe, Asia Pacific and Rest of world). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the lancets market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, and services; key strategies; Contracts, partnerships, agreements. new product & service launches, mergers and acquisitions, and recent developments associated with the lancets market. Competitive analysis of upcoming startups in the Lancets market ecosystem is covered in this report.

Key Benefits of Buying the Report:

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall Lancets market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and to plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

The report provides insights on the following pointers:

  • Analysis of key drivers (Growing prevalence of diabetes and increasing adoption of self-monitoring devices, Rising prevalence of various chronic diseases, Increasing demand for painless lancets, Growing geriatric population, Rising number of hospitals and surgical centers), restraints (Increasing incidence of lancet-related needlestick injuries and infections and Pricing pressure owing to reimbursement cuts and budget constraints) opportunities (Increasing incidence of lancet-related needlestick injuries and infections and Pricing pressure owing to reimbursement cuts and budget constraints), and challenges (Reuse of lancets) influencing the growth of the lancets market
  • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the Lancets market.
  • Market Development: Comprehensive information about lucrative markets - the report analyses the lancets market across varied regions.
  • Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the Lancets market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies and service offerings of leading players like Becton, Dickinson and Company (US), F. Hoffmann-La Roche Ltd. (Switzerland), B. Braun SE (Germany), Abbott Laboratories (US), and Greiner Bio-One International GmbH (Austria) and Terumo Corporation (Japan) among others in the lancets market strategies.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS AND EXCLUSIONS
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKETS COVERED
    • FIGURE 1 LANCETS MARKET SEGMENTATION
    • 1.3.2 GEOGRAPHIC SCOPE
    • 1.3.3 YEARS CONSIDERED
  • 1.4 CURRENCY CONSIDERED
  • 1.5 LIMITATIONS
  • 1.6 MARKET STAKEHOLDERS
  • 1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • FIGURE 2 RESEARCH DESIGN
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Secondary sources
    • 2.1.2 PRIMARY DATA
    • FIGURE 3 PRIMARY SOURCES
      • 2.1.2.1 Key data from primary sources
      • 2.1.2.2 Key industry insights
      • 2.1.2.3 Breakdown of primary interviews
    • FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY- AND DEMAND- SIDE PARTICIPANTS
    • FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS
  • 2.2 MARKET SIZE ESTIMATION
    • FIGURE 6 REVENUE SHARE ANALYSIS ILLUSTRATION
    • TABLE 1 LANCETS MARKET: COUNTRY-LEVEL ANALYSIS (1/2)
    • FIGURE 7 LANCETS MARKET: COUNTRY-LEVEL ANALYSIS (2/2)
    • 2.2.1 GROWTH FORECAST
    • FIGURE 8 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
    • FIGURE 9 TOP-DOWN APPROACH
  • 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
    • FIGURE 10 DATA TRIANGULATION METHODOLOGY
  • 2.4 MARKET SHARE ANALYSIS
  • 2.5 ASSUMPTIONS
  • 2.6 MARKET INDICATORS AND THEIR IMPACT
  • 2.7 RISK ASSESSMENT
    • TABLE 2 RISK ASSESSMENT
  • 2.8 IMPACT OF RECESSION: LANCETS MARKET

3 EXECUTIVE SUMMARY

    • FIGURE 11 LANCETS MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION)
    • FIGURE 12 LANCETS MARKET, BY GAUGE SIZE, 2023 VS. 2028 (USD MILLION)
    • FIGURE 13 LANCETS MARKET, BY AGE GROUP, 2023 VS. 2028 (USD MILLION)
    • FIGURE 14 LANCETS MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)
    • FIGURE 15 LANCETS MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
    • FIGURE 16 GEOGRAPHICAL SNAPSHOT OF LANCETS MARKET

4 PREMIUM INSIGHTS

  • 4.1 LANCETS MARKET OVERVIEW
    • FIGURE 17 INCREASING INCIDENCE OF DIABETES TO DRIVE MARKET
  • 4.2 NORTH AMERICA: LANCETS MARKET, BY TYPE AND COUNTRY (2022)
    • FIGURE 18 SAFETY LANCETS HELD LARGEST SHARE OF NORTH AMERICAN MARKET IN 2022
  • 4.3 LANCETS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
    • FIGURE 19 CHINA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 20 LANCETS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • 5.2.1 DRIVERS
      • 5.2.1.1 Growing prevalence of diabetes and increasing adoption of self-monitoring devices
    • FIGURE 21 INCIDENCE OF DIABETES, 2021 VS. 2045 (MILLION)
      • 5.2.1.2 Rising prevalence of various chronic diseases
    • FIGURE 22 US: NUMBER OF PEOPLE WITH CHRONIC CONDITIONS, 1995-2030 (MILLION)
      • 5.2.1.3 Increasing demand for painless lancets
      • 5.2.1.4 Growing geriatric population
    • TABLE 3 GLOBAL GERIATRIC POPULATION, BY REGION, 2019 VS. 2030
      • 5.2.1.5 Rising number of hospitals and surgical centers
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Increasing incidence of lancet-related needlestick injuries and infections
      • 5.2.2.2 Pricing pressure owing to reimbursement cuts and budget constraints
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 High growth prospects in emerging countries
      • 5.2.3.2 Increasing awareness of novel technologies
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Reuse of lancets
  • 5.3 VALUE CHAIN ANALYSIS
    • FIGURE 23 VALUE CHAIN ANALYSIS: MAJOR VALUE ADDED DURING MANUFACTURING AND ASSEMBLY PHASES
  • 5.4 SUPPLY CHAIN ANALYSIS
    • FIGURE 24 DIRECT DISTRIBUTION-PREFERRED STRATEGY FOR PROMINENT COMPANIES
  • 5.5 PORTER'S FIVE FORCES ANALYSIS
    • 5.5.1 THREAT OF NEW ENTRANTS
    • 5.5.2 INTENSITY OF COMPETITIVE RIVALRY
    • 5.5.3 BARGAINING POWER OF BUYERS
    • 5.5.4 BARGAINING POWER OF SUPPLIERS
    • 5.5.5 THREAT OF SUBSTITUTES
  • 5.6 KEY STAKEHOLDERS AND BUYING CRITERIA
    • 5.6.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • FIGURE 25 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR HOSPITALS, CLINICS, AND AMBULATORY SURGERY CENTERS
    • TABLE 4 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP END USERS (%)
    • 5.6.2 BUYING CRITERIA
    • FIGURE 26 KEY BUYING CRITERIA FOR HOSPITALS, CLINICS, AND AMBULATORY SURGERY CENTERS
    • TABLE 5 KEY BUYING CRITERIA FOR HOSPITALS, CLINICS, AND AMBULATORY SURGERY CENTERS
  • 5.7 REGULATORY LANDSCAPE
    • 5.7.1 NORTH AMERICA
      • 5.7.1.1 US
      • 5.7.1.2 Canada
    • TABLE 6 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
    • 5.7.2 EUROPE
    • 5.7.3 ASIA PACIFIC
      • 5.7.3.1 Japan
    • TABLE 7 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA
      • 5.7.3.2 China
    • TABLE 8 CHINA: CLASSIFICATION OF MEDICAL DEVICES
      • 5.7.3.3 India
  • 5.8 TRADE ANALYSIS
    • TABLE 9 IMPORT DATA FOR HS CODE 901839, BY COUNTRY, 2018-2022 (USD MILLION)
    • TABLE 10 EXPORT DATA FOR HS CODE 901839, BY COUNTRY, 2018-2022 (USD MILLION)
  • 5.9 ECOSYSTEM ANALYSIS
    • TABLE 11 ROLE IN ECOSYSTEM
    • FIGURE 27 KEY PLAYERS OPERATING IN LANCETS MARKET
  • 5.10 PATENT ANALYSIS
  • 5.11 KEY CONFERENCES AND EVENTS IN 2023-2024
    • TABLE 12 LIST OF CONFERENCES AND EVENTS
  • 5.12 PRICING ANALYSIS
    • 5.12.1 AVERAGE SELLING PRICE OF KEY PRODUCTS
    • TABLE 13 PRICE RANGE OF KEY PRODUCTS IN THE LANCETS MARKET (USD)
  • 5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • 5.14 TECHNOLOGY ANALYSIS

6 LANCETS MARKET, BY TYPE

  • 6.1 INTRODUCTION
    • FIGURE 28 LANCETS MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION)
    • TABLE 14 LANCETS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • 6.2 SAFETY LANCETS
    • TABLE 15 SAFETY LANCETS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 16 SAFETY LANCETS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • 6.2.1 MANUALLY ACTIVATED LANCETS
    • TABLE 17 MANUALLY ACTIVATED LANCETS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 18 MANUALLY ACTIVATED LANCETS MARKET, BY REGION, 2021-2028 (USD MILLION)
      • 6.2.1.1 Side-button lancets
        • 6.2.1.1.1 Anti-reuse measures to increase popularity among end users
    • TABLE 19 SIDE-BUTTON LANCETS MARKET, BY REGION, 2021-2028 (USD MILLION)
      • 6.2.1.2 Push-button lancets
        • 6.2.1.2.1 Ease of use and simplicity to drive demand
    • TABLE 20 PUSH-BUTTON LANCETS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • 6.2.2 AUTOMATICALLY ACTIVATED/PRESSURE-ACTIVATED LANCETS
      • 6.2.2.1 Available in number of gauge sizes and penetration depths
    • TABLE 21 AUTOMATICALLY ACTIVATED/PRESSURE-ACTIVATED LANCETS MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 6.3 STANDARD LANCETS
    • 6.3.1 INCREASING PREVALENCE OF DIABETES TO DRIVE ADOPTION
    • TABLE 22 STANDARD LANCETS MARKET, BY REGION, 2021-2028 (USD MILLION)

7 LANCETS MARKET, BY GAUGE SIZE

  • 7.1 INTRODUCTION
    • FIGURE 29 LANCETS MARKET, BY GAUGE SIZE, 2023 VS. 2028 (USD MILLION)
    • TABLE 23 LANCETS MARKET, BY GAUGE SIZE, 2021-2028 (USD MILLION)
  • 7.2 22G AND BELOW
    • 7.2.1 BENEFICIAL FOR MEDICAL TESTS THAT REQUIRE LARGER SAMPLE SIZE
    • TABLE 24 22G AND BELOW LANCETS MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 7.3 23G-33G
    • 7.3.1 WIDE AVAILABILITY OF 23G-33G LANCETS TO AID MARKET GROWTH
    • TABLE 25 23G-33G LANCETS MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 7.4 ABOVE 33G
    • 7.4.1 LESS PAIN AND DISCOMFORT TO DRIVE ADOPTION
    • TABLE 26 ABOVE 33G LANCETS MARKET, BY REGION, 2021-2028 (USD MILLION)

8 LANCETS MARKET, BY AGE GROUP

  • 8.1 INTRODUCTION
    • FIGURE 30 LANCETS MARKET, BY AGE GROUP, 2023 VS. 2028 (USD MILLION)
    • TABLE 27 LANCETS MARKET, BY AGE GROUP, 2021-2028 (USD MILLION)
  • 8.2 ADULT
    • 8.2.1 LARGEST AND FASTEST-GROWING SEGMENT
    • TABLE 28 ADULT LANCETS MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 8.3 PEDIATRIC
    • 8.3.1 INCREASING PREVALENCE OF TYPE 1 DIABETES IN PEDIATRIC PATIENTS TO DRIVE MARKET
    • TABLE 29 PEDIATRIC LANCETS MARKET, BY REGION, 2021-2028 (USD MILLION)

9 LANCETS MARKET, BY APPLICATION

  • 9.1 INTRODUCTION
    • FIGURE 31 LANCETS MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)
    • TABLE 30 LANCETS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • 9.2 GLUCOSE TESTING
    • 9.2.1 RISING PREVALENCE OF DIABETES TO DRIVE MARKET
    • TABLE 31 LANCETS MARKET FOR GLUCOSE TESTING, BY REGION, 2021-2028 (USD MILLION)
  • 9.3 HEMOGLOBIN TESTING
    • 9.3.1 HIGH PREVALENCE OF ANEMIA TO DRIVE DEMAND
    • TABLE 32 LANCETS MARKET FOR HEMOGLOBIN TESTING, BY REGION, 2021-2028 (USD MILLION)
  • 9.4 COAGULATION TESTING
    • 9.4.1 RISING PREVALENCE OF LIVER DISEASES, THROMBOPHILIA, AND HEMOPHILIA TO DRIVE MARKET
    • TABLE 33 LANCETS MARKET FOR COAGULATION TESTING, BY REGION, 2021-2028 (USD MILLION)
  • 9.5 CHOLESTEROL TESTING
    • 9.5.1 RISING DEMAND FOR CHOLESTEROL HOME TEST KITS TO SUPPORT MARKET GROWTH
    • TABLE 34 LANCETS MARKET FOR CHOLESTEROL TESTING, BY REGION, 2021-2028 (USD MILLION)
  • 9.6 ALLERGY TESTING
    • 9.6.1 HIGH DEMAND FOR SPT TO PROPEL MARKET
    • TABLE 35 LANCETS MARKET FOR ALLERGY TESTING, BY REGION, 2021-2028 (USD MILLION)
  • 9.7 NEONATAL SCREENING
    • 9.7.1 GROWING NEED FOR DRY BLOOD SPOT TESTS TO DRIVE MARKET
    • TABLE 36 LANCETS MARKET FOR NEONATAL SCREENING, BY REGION, 2021-2028 (USD MILLION)
  • 9.8 OTHER APPLICATIONS
    • TABLE 37 LANCETS MARKET FOR OTHER APPLICATIONS, BY REGION, 2021-2028 (USD MILLION)

10 LANCETS MARKET, BY END USER

  • 10.1 INTRODUCTION
    • FIGURE 32 LANCETS MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
    • TABLE 38 LANCETS MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 10.2 HOSPITALS, CLINICS, AND AMBULATORY SURGERY CENTERS
    • 10.2.1 INCREASING INCIDENCE OF CHRONIC DISEASES TO DRIVE ADOPTION OF LANCETS
    • TABLE 39 LANCETS MARKET FOR HOSPITALS, CLINICS, AND AMBULATORY SURGERY CENTERS, BY REGION, 2021-2028 (USD MILLION)
  • 10.3 HOME CARE SETTINGS
    • 10.3.1 TECHNOLOGICAL ADVANCEMENTS IN SELF/HOME CARE GLUCOSE MONITORING SYSTEMS TO DRIVE MARKET
    • TABLE 40 LANCETS MARKET FOR HOME CARE SETTINGS, BY REGION, 2021-2028 (USD MILLION)
  • 10.4 OTHER END USERS
    • TABLE 41 LANCETS MARKET FOR OTHER END USERS, BY REGION, 2021-2028 (USD MILLION)

11 LANCETS MARKET, BY REGION

  • 11.1 INTRODUCTION
    • TABLE 42 LANCETS MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 11.2 NORTH AMERICA
    • 11.2.1 NORTH AMERICA: IMPACT OF RECESSION
    • FIGURE 33 NORTH AMERICA: LANCETS MARKET SNAPSHOT
    • TABLE 43 NORTH AMERICA: LANCETS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 44 NORTH AMERICA: LANCETS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 45 NORTH AMERICA: SAFETY LANCETS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 46 NORTH AMERICA: MANUALLY ACTIVATED LANCETS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 47 NORTH AMERICA: LANCETS MARKET, BY GAUGE SIZE, 2021-2028 (USD MILLION)
    • TABLE 48 NORTH AMERICA: LANCETS MARKET, BY AGE GROUP, 2021-2028 (USD MILLION)
    • TABLE 49 NORTH AMERICA: LANCETS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 50 NORTH AMERICA: LANCETS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 11.2.2 US
      • 11.2.2.1 Increasing incidence and prevalence of lifestyle diseases to drive market
    • TABLE 51 US: LANCETS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 52 US: SAFETY LANCETS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 53 US: MANUALLY ACTIVATED LANCETS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 54 US: LANCETS MARKET, BY GAUGE SIZE, 2021-2028 (USD MILLION)
    • TABLE 55 US: LANCETS MARKET, BY AGE GROUP, 2021-2028 (USD MILLION)
    • TABLE 56 US: LANCETS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 57 US: LANCETS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 11.2.3 CANADA
      • 11.2.3.1 Rising incidence of allergies to drive market
    • TABLE 58 CANADA: LANCETS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 59 CANADA: SAFETY LANCETS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 60 CANADA: MANUALLY ACTIVATED LANCETS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 61 CANADA: LANCETS MARKET, BY GAUGE SIZE, 2021-2028 (USD MILLION)
    • TABLE 62 CANADA: LANCETS MARKET, BY AGE GROUP, 2021-2028 (USD MILLION)
    • TABLE 63 CANADA: LANCETS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 64 CANADA: LANCETS MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 11.3 EUROPE
    • 11.3.1 EUROPE: IMPACT OF RECESSION
    • TABLE 65 EUROPE: LANCETS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 66 EUROPE: LANCETS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 67 EUROPE: SAFETY LANCETS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 68 EUROPE: MANUALLY ACTIVATED LANCETS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 69 EUROPE: LANCETS MARKET, BY GAUGE SIZE, 2021-2028 (USD MILLION)
    • TABLE 70 EUROPE: LANCETS MARKET, BY AGE GROUP, 2021-2028 (USD MILLION)
    • TABLE 71 EUROPE: LANCETS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 72 EUROPE: LANCETS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 11.3.2 GERMANY
      • 11.3.2.1 Germany to dominate European lancets market
    • TABLE 73 GERMANY: LANCETS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 74 GERMANY: SAFETY LANCETS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 75 GERMANY: MANUALLY ACTIVATED LANCETS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 76 GERMANY: LANCETS MARKET, BY GAUGE SIZE, 2021-2028 (USD MILLION)
    • TABLE 77 GERMANY: LANCETS MARKET, BY AGE GROUP, 2021-2028 (USD MILLION)
    • TABLE 78 GERMANY: LANCETS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 79 GERMANY: LANCETS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 11.3.3 FRANCE
      • 11.3.3.1 Growing public-private collaborations for product development to support market growth
    • TABLE 80 FRANCE: LANCETS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 81 FRANCE: SAFETY LANCETS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 82 FRANCE: MANUALLY ACTIVATED LANCETS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 83 FRANCE: LANCETS MARKET, BY GAUGE SIZE, 2021-2028 (USD MILLION)
    • TABLE 84 FRANCE: LANCETS MARKET, BY AGE GROUP, 2021-2028 (USD MILLION)
    • TABLE 85 FRANCE: LANCETS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 86 FRANCE: LANCETS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 11.3.4 UK
      • 11.3.4.1 Increasing prevalence of lifestyle diseases to drive market
    • TABLE 87 UK: LANCETS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 88 UK: SAFETY LANCETS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 89 UK: MANUALLY ACTIVATED LANCETS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 90 UK LANCETS MARKET, BY GAUGE SIZE, 2021-2028 (USD MILLION)
    • TABLE 91 UK: LANCETS MARKET, BY AGE GROUP, 2021-2028 (USD MILLION)
    • TABLE 92 UK: LANCETS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 93 UK: LANCETS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 11.3.5 ITALY
      • 11.3.5.1 Slower growth in healthcare sector to restrain market growth
    • TABLE 94 ITALY: LANCETS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 95 ITALY: SAFETY LANCETS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 96 ITALY: MANUALLY ACTIVATED LANCETS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 97 ITALY: LANCETS MARKET, BY GAUGE SIZE, 2021-2028 (USD MILLION)
    • TABLE 98 ITALY: LANCETS MARKET, BY AGE GROUP, 2021-2028 (USD MILLION)
    • TABLE 99 ITALY: LANCETS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 100 ITALY: LANCETS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 11.3.6 SPAIN
      • 11.3.6.1 Increasing funding for research to boost market growth
    • TABLE 101 SPAIN: LANCETS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 102 SPAIN: SAFETY LANCETS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 103 SPAIN: MANUALLY ACTIVATED LANCETS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 104 SPAIN: LANCETS MARKET, BY GAUGE SIZE, 2021-2028 (USD MILLION)
    • TABLE 105 SPAIN: LANCETS MARKET, BY AGE GROUP, 2021-2028 (USD MILLION)
    • TABLE 106 SPAIN: LANCETS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 107 SPAIN: LANCETS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 11.3.7 REST OF EUROPE
    • TABLE 108 REST OF EUROPE: LANCETS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 109 REST OF EUROPE: SAFETY LANCETS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 110 REST OF EUROPE: MANUALLY ACTIVATED LANCETS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 111 REST OF EUROPE: LANCETS MARKET, BY GAUGE SIZE, 2021-2028 (USD MILLION)
    • TABLE 112 REST OF EUROPE: LANCETS MARKET, BY AGE GROUP, 2021-2028 (USD MILLION)
    • TABLE 113 REST OF EUROPE: LANCETS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 114 REST OF EUROPE: LANCETS MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 11.4 ASIA PACIFIC
    • 11.4.1 ASIA PACIFIC: IMPACT OF RECESSION
    • FIGURE 34 ASIA PACIFIC: LANCETS MARKET SNAPSHOT
    • TABLE 115 ASIA PACIFIC: LANCETS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 116 ASIA PACIFIC: LANCETS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 117 ASIA PACIFIC: SAFETY LANCETS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 118 ASIA PACIFIC: MANUALLY ACTIVATED LANCETS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 119 ASIA PACIFIC: LANCETS MARKET, BY GAUGE SIZE, 2021-2028 (USD MILLION)
    • TABLE 120 ASIA PACIFIC: LANCETS MARKET, BY AGE GROUP, 2021-2028 (USD MILLION)
    • TABLE 121 ASIA PACIFIC: LANCETS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 122 ASIA PACIFIC: LANCETS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 11.4.2 JAPAN
      • 11.4.2.1 Well-established healthcare system to support market growth
    • TABLE 123 JAPAN: LANCETS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 124 JAPAN: SAFETY LANCETS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 125 JAPAN: MANUALLY ACTIVATED LANCETS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 126 JAPAN: LANCETS MARKET, BY GAUGE SIZE, 2021-2028 (USD MILLION)
    • TABLE 127 JAPAN: LANCETS MARKET, BY AGE GROUP, 2021-2028 (USD MILLION)
    • TABLE 128 JAPAN: LANCETS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 129 JAPAN: LANCETS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 11.4.3 CHINA
      • 11.4.3.1 Fastest-growing market for lancets
    • TABLE 130 CHINA: LANCETS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 131 CHINA: SAFETY LANCETS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 132 CHINA: MANUALLY ACTIVATED LANCETS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 133 CHINA: LANCETS MARKET, BY GAUGE SIZE, 2021-2028 (USD MILLION)
    • TABLE 134 CHINA: LANCETS MARKET, BY AGE GROUP, 2021-2028 (USD MILLION)
    • TABLE 135 CHINA: LANCETS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 136 CHINA: LANCETS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 11.4.4 INDIA
      • 11.4.4.1 High burden of chronic diseases to support market growth
    • TABLE 137 INDIA: LANCETS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 138 INDIA: SAFETY LANCETS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 139 INDIA: MANUALLY ACTIVATED LANCETS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 140 INDIA: LANCETS MARKET, BY GAUGE SIZE, 2021-2028 (USD MILLION)
    • TABLE 141 INDIA: LANCETS MARKET, BY AGE GROUP, 2021-2028 (USD MILLION)
    • TABLE 142 INDIA: LANCETS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 143 INDIA: LANCETS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 11.4.5 SOUTH KOREA
      • 11.4.5.1 Increasing government initiatives to aid market growth
    • TABLE 144 SOUTH KOREA: LANCETS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 145 SOUTH KOREA: SAFETY LANCETS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 146 SOUTH KOREA: MANUALLY ACTIVATED LANCETS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 147 SOUTH KOREA: LANCETS MARKET, BY GAUGE SIZE, 2021-2028 (USD MILLION)
    • TABLE 148 SOUTH KOREA: LANCETS MARKET, BY AGE GROUP, 2021-2028 (USD MILLION)
    • TABLE 149 SOUTH KOREA: LANCETS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 150 SOUTH KOREA: LANCETS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 11.4.6 REST OF ASIA PACIFIC
    • TABLE 151 REST OF ASIA PACIFIC: LANCETS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 152 REST OF ASIA PACIFIC: SAFETY LANCETS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 153 REST OF ASIA PACIFIC: MANUALLY ACTIVATED LANCETS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 154 REST OF ASIA PACIFIC: LANCETS MARKET, BY GAUGE SIZE, 2021-2028 (USD MILLION)
    • TABLE 155 REST OF ASIA PACIFIC: LANCETS MARKET, BY AGE GROUP, 2021-2028 (USD MILLION)
    • TABLE 156 REST OF ASIA PACIFIC: LANCETS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 157 REST OF ASIA PACIFIC: LANCETS MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 11.5 REST OF THE WORLD
    • TABLE 158 REST OF THE WORLD: LANCETS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 159 REST OF THE WORLD: LANCETS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 160 REST OF THE WORLD: SAFETY LANCETS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 161 REST OF THE WORLD: MANUALLY ACTIVATED LANCETS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 162 REST OF THE WORLD: LANCETS MARKET, BY GAUGE SIZE, 2021-2028 (USD MILLION)
    • TABLE 163 REST OF THE WORLD: LANCETS MARKET, BY AGE GROUP, 2021-2028 (USD MILLION)
    • TABLE 164 REST OF THE WORLD: LANCETS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 165 REST OF THE WORLD: LANCETS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 11.5.1 LATIN AMERICA
      • 11.5.1.1 Rising prevalence of diabetes and cancer to support market growth
      • 11.5.1.2 Latin America: Impact of recession
    • TABLE 166 LATIN AMERICA: LANCETS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 167 LATIN AMERICA: SAFETY LANCETS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 168 LATIN AMERICA: MANUALLY ACTIVATED LANCETS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 169 LATIN AMERICA: LANCETS MARKET, BY GAUGE SIZE, 2021-2028 (USD MILLION)
    • TABLE 170 LATIN AMERICA: LANCETS MARKET, BY AGE GROUP, 2021-2028 (USD MILLION)
    • TABLE 171 LATIN AMERICA: LANCETS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 172 LATIN AMERICA: LANCETS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 11.5.2 MIDDLE EAST AND AFRICA
      • 11.5.2.1 Rising geriatric population and increasing prevalence of chronic diseases to drive market
      • 11.5.2.2 Middle East & Africa: Impact of recession
    • TABLE 173 MIDDLE EAST AND AFRICA: LANCETS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 174 MIDDLE EAST AND AFRICA: SAFETY LANCETS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 175 MIDDLE EAST AND AFRICA: MANUALLY ACTIVATED LANCETS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 176 MIDDLE EAST AND AFRICA: LANCETS MARKET, BY GAUGE SIZE, 2021-2028 (USD MILLION)
    • TABLE 177 MIDDLE EAST AND AFRICA: LANCETS MARKET, BY AGE GROUP, 2021-2028 (USD MILLION)
    • TABLE 178 MIDDLE EAST AND AFRICA: LANCETS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 179 MIDDLE EAST AND AFRICA: LANCETS MARKET, BY END USER, 2021-2028 (USD MILLION)

12 COMPETITIVE LANDSCAPE

  • 12.1 OVERVIEW
    • TABLE 180 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN LANCETS MARKET
  • 12.2 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
    • FIGURE 35 REVENUE SHARE ANALYSIS OF TOP PLAYERS IN LANCETS MARKET
  • 12.3 MARKET SHARE ANALYSIS
    • TABLE 181 LANCETS MARKET: DEGREE OF COMPETITION
  • 12.4 COMPETITIVE LEADERSHIP MAPPING
    • 12.4.1 STARS
    • 12.4.2 EMERGING LEADERS
    • 12.4.3 PERVASIVE PLAYERS
    • 12.4.4 PARTICIPANTS
    • FIGURE 36 LANCETS MARKET: COMPANY EVALUATION QUADRANT FOR KEY PLAYERS, 2022
  • 12.5 COMPANY EVALUATION QUADRANT FOR SMES/STARTUPS
    • 12.5.1 PROGRESSIVE COMPANIES
    • 12.5.2 STARTING BLOCKS
    • 12.5.3 RESPONSIVE COMPANIES
    • 12.5.4 DYNAMIC COMPANIES
    • FIGURE 37 LANCETS MARKET: COMPANY EVALUATION MATRIX FOR SMES/STARTUPS, 2022
  • 12.6 COMPETITIVE BENCHMARKING
    • TABLE 182 LANCETS MARKET: DETAILED LIST OF KEY STARTUPS/SMES
  • 12.7 COMPANY FOOTPRINT ANALYSIS
    • TABLE 183 FOOTPRINT ANALYSIS OF COMPANIES
    • TABLE 184 REGIONAL FOOTPRINT ANALYSIS OF COMPANIES
    • TABLE 185 PRODUCT FOOTPRINT ANALYSIS OF COMPANIES
  • 12.8 COMPETITIVE SCENARIO
    • 12.8.1 PRODUCT LAUNCHES
    • TABLE 186 KEY PRODUCT LAUNCHES, JANUARY 2020-MAY 2023
    • 12.8.2 DEALS
    • TABLE 187 KEY DEALS, JANUARY 2020-MAY 2023
    • 12.8.3 OTHER DEVELOPMENTS
    • TABLE 188 OTHER KEY DEVELOPMENTS, JANUARY 2020-MAY 2023

13 COMPANY PROFILES

  • 13.1 KEY PLAYERS
  • (Business overview, Products offered, Recent Developments, MNM view)**
    • 13.1.1 BECTON, DICKINSON AND COMPANY
    • TABLE 189 BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW
    • FIGURE 38 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2022)
    • 13.1.2 F. HOFFMANN-LA ROCHE LTD.
    • TABLE 190 F. HOFFMANN-LA ROCHE LTD.: BUSINESS OVERVIEW
    • FIGURE 39 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2022)
    • 13.1.3 YPSOMED
    • TABLE 191 YPSOMED: BUSINESS OVERVIEW
    • FIGURE 40 YPSOMED: COMPANY SNAPSHOT (2022)
    • 13.1.4 B. BRAUN SE
    • TABLE 192 B. BRAUN SE: BUSINESS OVERVIEW
    • FIGURE 41 B. BRAUN SE: COMPANY SNAPSHOT (2022)
    • 13.1.5 TERUMO CORPORATION
    • TABLE 193 TERUMO CORPORATION: BUSINESS OVERVIEW
    • FIGURE 42 TERUMO CORPORATION: COMPANY SNAPSHOT (2022)
    • 13.1.6 GREINER BIO-ONE INTERNATIONAL GMBH
    • TABLE 194 GREINER BIO-ONE INTERNATIONAL GMBH: BUSINESS OVERVIEW
    • FIGURE 43 GREINER BIO-ONE INTERNATIONAL GMBH: COMPANY SNAPSHOT (2021)
    • 13.1.7 ABBOTT LABORATORIES
    • TABLE 195 ABBOTT LABORATORIES: BUSINESS OVERVIEW
    • FIGURE 44 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2022)
    • 13.1.8 OWEN MUMFORD
    • TABLE 196 OWEN MUMFORD: BUSINESS OVERVIEW
    • 13.1.9 HTL-STREFA S.A.
    • TABLE 197 HTL-STREFA S.A.: BUSINESS OVERVIEW
    • 13.1.10 ARKRAY, INC.
    • TABLE 198 ARKRAY, INC.: BUSINESS OVERVIEW
    • 13.1.11 SARSTEDT AG & CO. KG
    • TABLE 199 SARSTEDT AG & CO. KG: BUSINESS OVERVIEW
    • 13.1.12 STERILANCE MEDICAL (SUZHOU) INC.
    • TABLE 200 STERILANCE MEDICAL (SUZHOU): BUSINESS OVERVIEW
    • 13.1.13 MEDLINE INDUSTRIES
    • TABLE 201 MEDLINE INDUSTRIES: BUSINESS OVERVIEW
    • 13.1.14 AGAMATRIX, INC.
    • TABLE 202 AGAMATRIX, INC.: BUSINESS OVERVIEW
    • 13.1.15 ACON LABORATORIES, INC.
    • TABLE 203 ACON LABORATORIES, INC.: BUSINESS OVERVIEW
    • 13.1.16 SANLI MEDICAL & HEALTH SERVICE
    • TABLE 204 SANLI MEDICAL & HEALTH SERVICE: BUSINESS OVERVIEW
    • 13.1.17 ALLISON MEDICAL, INC.
    • TABLE 205 ALLISON MEDICAL, INC.: BUSINESS OVERVIEW
    • 13.1.18 GLUCORX LIMITED
    • TABLE 206 GLUCORX LIMITED: BUSINESS OVERVIEW
  • *Details on Business overview, Products offered, Recent Developments, MNM view might not be captured in case of unlisted companies.
  • 13.2 OTHER PLAYERS
    • 13.2.1 FL MEDICAL S.R.L
    • 13.2.2 MHC MEDICAL PRODUCTS, LLC
    • 13.2.3 NEOMEDIC
    • 13.2.4 CML BIOTECH LTD.
    • 13.2.5 DISERA TIBBI MALZEME LOJISTIK SANAYI VE TICARET A.S.
    • 13.2.6 A. MENARINI DIAGNOSTICS S.R.L

14 APPENDIX

  • 14.1 DISCUSSION GUIDE
  • 14.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 14.3 CUSTOMIZATION OPTIONS
  • 14.4 RELATED REPORTS
  • 14.5 AUTHOR DETAILS